AstraZeneca Stays in London: A Win for the UK?
Update: 2025-09-29
Description
AstraZeneca Stays in London: Pharma Giant's NYSE Listing a Win for UK? AstraZeneca's decision to directly list on the NYSE while keeping its primary listing and headquarters in London sends a powerful message. Amid fears of companies fleeing to the US, this move could reassure investors and influence other major players to stay committed to the London market. Will AstraZeneca's commitment stem the tide, or will the lure of higher valuations in the US prove too strong for others?
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
